Use of Cartilage Derived From Murine Induced Pluripotent Stem Cells for Osteoarthritis Drug Screening

Publisher： John Wiley & Sons Inc

E-ISSN： 2326-5205|66|11|3062-3072

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.66, Iss.11, 2014-11, pp. : 3062-3072

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The case for induced pluripotent stem cell‐derived cardiomyocytes in pharmacological screening

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 169, Iss. 2, 2013-05 ,pp. : 304-317

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human pluripotent stem cells for genetic disease modeling and drug screening

By Gauthier Morgane   Maury Yves   Peschanski Marc   Martinat Cécile  

Regenerative Medicine, Vol. 6, Iss. 5, 2011-09 ,pp. : 607-622

Future Medicine

Access to resources Recommend Favorite

Potential of human induced pluripotent stem cells derived from blood and other postnatal cell types

By Ye Zhaohui   Cheng Linzhao  

Regenerative Medicine, Vol. 5, Iss. 4, 2010-07 ,pp. : 521-530

Future Medicine

Access to resources Recommend Favorite

Converging technologies to enable induced pluripotent stem cells in drug discovery

By Flynn Peter   Yingling Jessica   Shoemaker Dan  

Regenerative Medicine, Vol. 5, Iss. 4, 2010-07 ,pp. : 489-491

Future Medicine

Access to resources Recommend Favorite

Low-Density Neuronal Cultures from Human Induced Pluripotent Stem Cells

By  

Molecular Neuropsychiatry, Vol. 3, Iss. 1, 2017-06 ,pp. : 28-36

Karger

Access to resources Recommend Favorite